Advertisement

License Photo

CONGRESS LOOKS INTO VIOXX AND FDA
Mr. Raymond V. Gilmartin, Chairman, President & Chief Executive Officer, Merck & Co., Whitehouse Station, NJ testifies before the Senate Finance Committee hearing on FDA, Merck, and Vioxx on November 18, 2004 in Washington as Dr. David J. Graham of the Food and Drug Administration and Dr. Bruce M. Psaty look on. Vioxx was taken off the market because it was found to raise the risk of heart attacks. ..(UPI Photo/Michael Kleinfeld)

Please fill out form for pricing information for the photo below.
CONGRESS LOOKS INTO VIOXX AND FDA
Please enter the numbers you see to the right.